SCHEMBL1921664

SCHEMBL1921664

Nc1[c]cccc1-c1cccc(O)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 10/20 0.45
HSD17B2 P37059 9/20 0.45
CYP3A4 P08684 3/20 0.45
SRC P12931 2/20 0.45
CYP2C9 P11712 2/20 0.45
FLT3 P36888 2/20 0.45
CSNK1D P48730 2/20 0.45
DYRK1A Q13627 2/20 0.45
BRSK1 Q8TDC3 2/20 0.45
SRPK1 Q96SB4 2/20 0.45
CLK4 Q9HAZ1 2/20 0.45
MKNK2 Q9HBH9 2/20 0.45
DYRK1B Q9Y463 2/20 0.45
PLK4 O00444 1/20 0.45
ROCK2 O75116 1/20 0.45
RPS6KA5 O75582 1/20 0.45
MAP4K4 O95819 1/20 0.45
RET P07949 1/20 0.45
PDGFRB P09619 1/20 0.45
PIM1 P11309 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6824951 0.81 HSD17B1 (0.48) HSD17B1HSD17B2CYP3A4SRCCYP2C9
SCHEMBL2585790 0.81 MAP4K4 (0.49) CYP3A4MKNK2MAP4K4CA12ALDH1A1
SCHEMBL4911450 0.80 PARP1 (0.43) HSD17B1HSD17B2CYP3A4SRCCYP2C9
SCHEMBL4283341 0.79 HSD17B1 (0.45) HSD17B1HSD17B2CYP3A4SRCCYP2C9
SCHEMBL4285032 0.79 HSD17B1 (0.45) HSD17B1HSD17B2CYP3A4SRCCYP2C9
SCHEMBL4275992 0.79 HSD17B1 (0.50) HSD17B1HSD17B2CYP3A4SRCCYP2C9
SCHEMBL4288525 0.79 HSD17B1 (0.45) HSD17B1HSD17B2CYP3A4SRCCYP2C9
SCHEMBL8490974 0.78 PRKCI (0.44) LIMK1LRRK2ADORA1MTOR
SCHEMBL7393282 0.77 ALDH1A1 (0.50) CYP3A4CLK4DYRK1BMAP4K4FGFR1
SCHEMBL4279339 0.75 HSD17B1 (0.41) HSD17B1HSD17B2CYP3A4SRCCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3357911-B1 PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE AKEBIA THERAPEUTICS INC (US) 2022-05-11 EP disclosed
EP-3357911-A1 PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE Akebia Therapeutics Inc. (US) 2018-08-08 EP disclosed
EP-3323807-A1 PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE Akebia Therapeutics, Inc. (US) 2018-05-23 EP disclosed
EP-2327696-A1 Prolyl hydroxylase inhibitors and methods of use Warner Chilcott Company, LLC (PR) 2011-06-01 EP disclosed